一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

CAL-101

CAL-101 Struktur
1146702-54-6
CAS-Nr.
1146702-54-6
Englisch Name:
CAL-101
Synonyma:
Idelalisib;GS-1101, Idelalisib;CAL-101, 10 mM in DMSO;CAL-101 (GS-1101, Idelalisib);5-fluoro-3-phenyl-2-((1s)-1-(1h-purin-6-ylamino)ethyl)-4(3h)...
CBNumber:
CB62638450
Summenformel:
C22H18FN7O
Molgewicht:
415.4230232
MOL-Datei:
1146702-54-6.mol

CAL-101 Eigenschaften

Sicherheit

CAL-101 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Idelalisib is an orally available selective and potent phosphatidylinositol 3-kinase δ (PI3 Kδ) inhibitor originally developed by Calistoga Pharmaceuticals, which was acquired by Gilead in April 2014. In July 2014, the drug was approved in the USA for the treatment of relapsed chronic lymphocytic leukemia as well as several oncology orphan drug designations. Since idelalisib specifically inhibits PI3Kd, which is expressed primarily in bloodcell lineages, the therapeutic effect is localized, limiting interference with PI3K isoform signaling that is critical to normal function of healthy cells.

Indications

Among the large groups of structural diverse lipid kinase inhibitors, especially against PI3Ks, idelalisib (Zydelig(R), Gilead Sciences) is the only inhibitor approved by FDA for the treatment of patients with relapsed chronic lymphocytic leukemia in combination with rituximab and patients with relapsed follicular B-cell non-Hodgkin lymphoma or small lymphocytic lymphoma.

Trademarks

Zydelig

Synthese

Commercial 2-fluoro-6-nitrobenzoic acid (117) was treated with oxalyl chloride in the presence of catalytic amount of N,Ndimethylformamide (DMF) in DCM to give the corresponding 2- fluoro-6-nitrobenzoyl chloride as a brown syrup, which was subsequently coupled with aniline under Schotten-Baumann conditions to yield 2-fluoro-6-nitro-N-phenylbenzamide 118 in 99% yield. Coupling of 118 with commercial N-Boc-2(S)-aminobutyric acid in the presence of Et3N in DCM generated imide 119 in 66% yield. Reductive cyclization of nitro imide 119 by means of zinc dust in acetic acid gave the cyclized quinazolinone 120 in 69% yield, which underwent immediate N-deprotection with TFA in DCM to furnish the corresponding free amine 121. Finally, a substitution reaction involving amine 121 and 6-bromopurine (122) in the presence of DIPEA in t-BuOH gave idelalisib (XV) as a solid in 50% yield.

Synthesis_1146702-54-6

CAL-101 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


CAL-101 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 55)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 33024 60
Career Henan Chemica Co
+86-0371-86658258 +8613203830695
laboratory@coreychem.com China 30224 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471;
sales@sarms4muscle.com China 10473 58
Hefei TNJ Chemical Industry Co.,Ltd.
+86-0551-65418684 +8618949823763
sales@tnjchem.com China 25356 58
Golden Pharma Co., Limited
+undefined18958062155
sales@zjgoldpharm.com China 5899 58
TargetMol Chemicals Inc.
+1-781-999-5354;
support@targetmol.com United States 39037 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8467 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8615965530500
nickzhang@hangyubiotech.com China 9947 58
HANGZHOU LEAP CHEM CO., LTD.
+86-571-87711850
market18@leapchem.com China 43333 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131956 58

  • CAL-101 (GS-1101, Idelalisib)
  • GS-1101, Idelalisib
  • 5-fluoro-3-phenyl-2-((1s)-1-(1h-purin-6-ylamino)ethyl)-4(3h)...
  • CAL-101, 10 mM in DMSO
  • Idelalisib
  • 1146702-54-6
Copyright 2019 ? ChemicalBook. All rights reserved
京山县| 金溪县| 怀远县| 长阳| 赤城县| 松原市| 察哈| 拜城县| 洛扎县| 安吉县| 涞水县| 雷州市| 喀什市| 威海市| 大庆市| 迁西县| 林甸县| 遂宁市| 读书| 伊春市| 汕头市| 彝良县| 吐鲁番市| 武功县| 金门县| 台前县| 泾川县| 青海省| 唐河县| 海南省| 大城县| 泰来县| 原平市| 新竹市| 浑源县| 左贡县| 武胜县| 汉川市| 明水县| 永宁县| 嘉鱼县|